EP Plenary session - Joint debate on Patents

Patentes y derechos de obtentor (debate)

Patents and plant breeders rights (debate)

Creación de protección mediante una patente unitaria - Protección mediante una patente unitaria - Sistema jurisdiccional para litigios en materia de patentes (debate)

Creation of unitary patent protection - Unitary patent protection - Jurisdictional system for patent disputes (debate)

Patentes sobre procedimientos biológicos esenciales (debate)

Patenting of essential biological processes (debate)

Workshop - Policy Departements and Administration : Stem cell Research and patenting

ENVI

Cooperación reforzada en el ámbito de la creación de una protección de patente unitaria (debate)

Enhanced cooperation in the area of the creation of unitary patent protection (debate)

JURI committee meeting. Exchange of views with Romanian Presidency. Presentation of study on Essential Patents and Internet of Things, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of JURI committee

Public Hearing - The Unitary patent : state of play in the context of Brexit

PAPADIMOULIS, Dimitrios (GUE/NGL, GR) - EP Vice-President

Plenary session week 51 2015 in Strasbourg - Patents and plant breeders rights - Oral question

Green meeting about patenting food and GMOs

JURI committee Hearing on Patent

Andreas MAVROYIANNIS, Raffaele BALDASSARRE, Martin SCHULZ - EP President

Lex Signing: European Unitary Patent Package

Plenary session week 50 -2012  in Strasbourg - European Patent

Press conference on the campaign against the patenting of biotechnical discoveries - No Patents on Life - with Nobel Prize for Literature winner Dario FO.

Martin SCHULZ - EP President, Evelyne GEBHARDT

Evelyne GEBHARDT and  M. THEN from No patents on Seeds Hand over a letter to Martin SCHULZ EP-President

Carl SCHLYTER, Raul ROMEVA I RUEDA, Elisabeth SCHROEDTER, Isabelle DURANT, Jose BOVE, Franziska BRANTNER, Martin HAUSLING, Jean-Paul BESSET, Nikos CHRYSOGELOS, Ulrike LUNACEK, Franziska KELLER

Greens / EFA group members stage a protest against patents in the agriculture sector

JURI Committee Meeting - Enhanced cooperation in the area of the creation of unitary patent protection with regard to the applicable translation arrangements

Illustration on the EU Patent at the Belgian Intellectual Property Office.

Press Conference on Biotechnical patents by: Eva LICHTENBERGER (Greens/EFA, AT) - Vittorio PRODI (S&D, IT) - Peter LIESE (EPP, DE)  - Miroslav MIKOLJIK (EPP, SL) - Carlo CASINI (EPP, IT)

Press conference in Strasbourg  : TRIPS and access to medicines - TRIPS : The EP was due to vote on whether to grant its assent to amending the TRIPS agreement to enable developing countries to make or import generic substitutes for patented medicines

No Software Patents demonstration at the EP in Strasbourg.

No Software Patents demonstration by the GreensEFA.

MEPs wear t-shirts with a slogan that reads 'Protect innovation against software patents'

Intellectual property lies at the heart of innovation and competitiveness around the world as well as in the European Union. Intellectual property rights are protected mainly through patents, trademarks and copyright. They enable individuals and companies to earn recognition and/or financial benefit from what they invent or create. By striking the right balance between innovators and public interest, intellectual property aims to foster an environment in which creativity and innovation can flourish. But despite impressive patent activity, European businesses still encounter various challenges to register or protect patents. Restrictions: ©The material may not be edited and must be shown entirely.

EPRS - Key challenges for European patents

El Parlamento ha debatido la posibilidad de suspender las patentes de las vacunas contra el Covid-19 y ha aprobado un programa Erasmus+ más inclusivo. El clima también figuró en la agenda: Los eurodiputados han aprobado el Fondo de Transición Justa para ayudar a las regiones a adaptarse a la transición verde y han instado a la UE a hacer algo más para proteger a los activistas climáticos. Los eurodiputados también han debatido sobre la escalada en el conflicto entre Israel y Palestina.

Temas candentes en el Pleno: patentes de las vacunas contra el Covid-19, Erasmus+ y medio ambiente

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate proposal to the WTO to waive intellectual property rights for COVID-19 vaccines, a move backed by the US administration. Extracts from the debate: statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs, Valdis DOMBROVSKIS, Executive Vice-President of the EC in charge of an Economy that works for People, Esther de LANGE (EPP, NL), Iratxe GARCÍA PÉREZ (S&D, ES), Dacian CIOLOŞ (Renew, RO), Tilly METZ (Greens/EFA, LU), Marc BOTENGA (The Left, BE), and Gilles LEBRETON (ID, FR).

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade and by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Council and Comission

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs and by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade.

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements Council and Commission

El Parlamento reiteró su llamamiento a garantizar el acceso libre al material de fitomejoramiento. Los eurodiputados quieren garantizar que los agricultores de la Unión Europea puedan innovar para encontrar soluciones a la crisis climática y a las nuevas enfermedades de las plantas. No se debe permitir que las multinacionales ricas patenten la vida natural, porque crearían monopolios que elevarían los precios de los alimentos.

No a las patentes sobre plantas y semillas obtenidas por selección natural

La recta final de la patente unitaria de la UE parece una cuesta empinada, pero este nuevo sistema ofrece recortar costes hasta en 32.000 euros por patente.

Reducir los costes de patentar una invención

La patente única europea  traerá muchas ventajas a las empresas de la UE, en opinión de Raffaele Baldassarre. Sophia in 't Veld señala a los que violan los derechos fundamentales en Europa.

7 días: La lucha por los derechos y una patente europea

Después de 30 años de negociación, este podría ser el último paso para lograr una patente única en la UE. Hablamos con el eurodiputado alemán Bernhard Rapkay y con el eurodiputado español Antonio Masip Hidalgo.

Tema de debate: La patente europea, ¿el paso definitivo?

El PE trata de avanzar hacia la patente para la UE, cuestionan la integridad de los Estados miembros y dan su opinión sobre el rescate a los bancos españoles; mientras tanto, los agricultores piden una subida en los precios de la leche.

Patente Europea / Vuelos de la CIA / España / Leche

Los eurodiputados quieren examinar detenidamente el futuro de la patente única europea después de la polémica en torno a la decisión unilateral del Consejo de modificar el texto acordado.

Un problema patente

Cuesta 2000 euros en EE. UU. y hasta 40 000 euros en Europa. La patente única europea debería simplificar y abaratar las cosas, pero su aplicación es complicada.

Reportero: Patentar un invento en todo un continente

Proteger los inventos en toda la UE podría hacerse posible con menos presupuesto, pero hay que tener cuidado con los detalles. Y otros titulares del día.

Informativos: La patente en trámites de la UE

Proteger los inventos en toda la UE podría hacerse posible con menos presupuesto, pero hay que tener cuidado con los detalles.

El uso más eficiente de los recursos, la patente comunitaria y la comparecencia de un comisario: parte de lo que espera a los eurodiputados a su regreso a Bruselas.

24 resultados

EPRS - Key challenges for European patents

Temas candentes en el Pleno: patentes de las vacunas contra el Covid-19, Erasmus+ y medio ambiente

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Council and Comission

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements Council and Commission

No a las patentes sobre plantas y semillas obtenidas por selección natural

Reducir los costes de patentar una invención

7 días: La lucha por los derechos y una patente europea

Tema de debate: La patente europea, ¿el paso definitivo?

Patente Europea / Vuelos de la CIA / España / Leche

Un problema patente

Reportero: Patentar un invento en todo un continente

Informativos: La patente en trámites de la UE

Informativos: La patente en trámites de la UE

En la agenda: Salvar el planeta